VarroMed (oxalic acid dihydrate / formic acid) – Conditions or restrictions regarding supply and use - QP53AG

Updated on site: 21-Sep-2017

Isem tal-Mediċina: VarroMed
ATC: QP53AG
Sustanza: oxalic acid dihydrate / formic acid
Manifattur: BeeVital GmbH

A.MANUFACTURER RESPONSIBLE FOR BATCH RELEASE

Name and address of the manufacturer responsible for batch release

Lichtenheldt GmbH

D-23812 Wahlstedt

GERMANY

Labor L+S AG

D-97708 Bad Bocklet-Grossenbrach

GERMANY

The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.

B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE

Veterinary medicinal product not subject to prescription.

C.STATEMENT OF THE MRLs

The active substances in VarroMed, oxalic acid dihydrate and formic acid, are allowed substances as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:

Pharmacologically

Marker

Animal

MRL

Target

Other

Therapeutic

active substance

residue

species

 

tissues

provisions

classification

Oxalic acid

N/A

Bees

No MRL

N/A

NO

Anti-

 

 

 

required

 

ENTRY

infectious

 

 

 

 

 

 

agents

 

 

 

 

 

 

 

Formic acid

N/A

All food

No MRL

N/A

NO

NO ENTRY

 

 

producing

required

 

ENTRY

 

 

 

species

 

 

 

 

 

 

 

 

 

 

 

The excipients, listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this product.

Kummenti